The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
The role of hypoxia-inducible factors in tumorigenesis
Open accessAbstract
Hypoxia-inducible factors (HIFs) are essential mediators of the cellular oxygen-signaling pathway. They are heterodimeric transcription factors consisting of an oxygen-sensitive alpha subunit (HIF-alpha) and a constitutive beta subunit (HIF-beta) that facilitate both oxygen delivery and adaptation to oxygen deprivation by regulating the expression of genes that control glucose uptake, metabolism, angiogenesis, erythropoiesis, cell proliferation, and apoptosis. In most experimental models, the HIF pathway is a positive regulator of tumor growth as its inhibition often results in tumor suppression. In clinical samples, HIF is found elevated and correlates with poor patient prognosis in a variety of cancers. In summary, HIF regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy, making it a critical regulator of the malignant phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIF-1 also controls the expression of genes involved in tumor cell immor- talization, stem cell maintenance/de-differentiation, genetic in- stability, autocrine growth, invasion/metastasis, and treatment failure (6, 7).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“Activation of HIF-1α will directly augment the transcription of genes involved in angiogenesis and metastasis, such as VEGF, MMP-9, lysyl oxidase and carbonic anhydrase IX (Rankin and Giaccia, 2008).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Rankin and Giaccia, 2008
In the citing paper
“Clinically, hypoxia is associated with HIF activation, metastasis, and resistance to chemotherapy and radiotherapy, as well as poor patient survival”
From Hypoxic control of metastasis (2016) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Self-citationRetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“Hydroxylation of conserved proline residues within the HIF-a ODD by prolyl-4hydroxylase domain (PHD)-containing proteins mediates pVHL binding and degradation.(20,21) Under hypoxia, HIF-a subunits are stabilized and translocate to the nucleus, where they heterodimerize with ARNT and bind to HREs located within regulat…”
BackgroundIdentification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J. R., Yao, M., Duh, F.-M. C., Orcutt, M. L., Stackhouse, T. M., Kuzmin, I., Modi, W. S., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,971
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 808
Park, S. Y., Nho, C. W., Kwon, D. Y., Kang, Y., Lee, K. W., & Park, J. H. Y. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000967 · Cited by 40
“HIF-1a can directly activate the expression of a variety of pro-angiogenic and pro-metastatic factors, including VEGF, VEGF receptors, E-cadherin, plasminogen activator inhibitor-1, uPAR, MMP-2 and MMP-9(23,25).”
BackgroundInfluentialAquino‐Gálvez, A., González-Ávila, G., DELGADO-TELLO, J., Castillejos-López, M. D. J., Mendoza-Milla, C., Zúñiga, J., Checa, M., Maldonado-Martínez, H. A., TRINIDAD-LÓPEZ, A., Cisneros, J., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4399 · Cited by 40
“There is evidence that HIF-1α mediates tumoral cell survival and apoptosis resistance under hypoxic and normoxic conditions (15,16-18).”
BackgroundDing, X., Zhou, X., Jiang, B., Zhao, Q., & Zhou, G. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3960 · Cited by 40
“However, HIF-1 α usually is induced by hypoxia and is not expressed in normoxic conditions, while it is highly expressed in pancreatic tumors and is associated with vessel generation in a number of tumor tissues (31).”
Li, M. Y., Mi, C., Wang, K. S., Wang, Z., Zuo, H. X., Piao, L. X., Xu, G. H., Li, X., Ma, J., & Jin, X. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.06.029 · Cited by 41
The Many Faces of Long Noncoding RNAs in Cancer
Wu, X., Tudoran, O. M., Călin, G. A., & Ivan, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7293 · Cited by 41
“It is estimated that more than half of solid tumors contain hypoxic regions (75) (11, 110) that represent sources of cells with aggressive phenotype and high resistance to therapy (42, 94, 98, 99).”
BackgroundHypoxia-Inducible Factor (HIF): Fuel for Cancer Progression
Satija, S., Kaur, H., Tambuwala, M. M., Sharma, P., Vyas, M., Khurana, N., Sharma, N., Bakshi, H. A., Charbe, N. B., Zacconi, F. C. M., et al. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210120154929 · Cited by 40
Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence
Traylor, J. I., Pernik, M. N., Plitt, A. R., Lim, M. K., & Garzón-Muvdi, T. (2021) · Cancers · doi:10.3390/cancers13102408 · Cited by 42
“Hypoxia inducible factor (HIF) is a key transcription factor in the cellular response to hypoxic conditions and has been implicated in tumor survival in ischemic conditions [59].”
BackgroundNeutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle?
Bolignano, D., Coppolino, G., Donato, V., Lacquaniti, A., Bono, C., & Buemi, M. (2010) · PubMed · Cited by 40
Ma, J., Li, J., Wang, K. S., Mi, C., Piao, L. X., Xu, G. H., Li, X., Lee, J. J., & Jin, X. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.06.034 · Cited by 39
HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma
Wang, X., Dong, J., Jia, L., Zhao, T., Lang, M., Li, Z., Lan, C., Li, X., Hao, J., Wang, H., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.032 · Cited by 39
“It is well known that hypoxic tumor microenvironment that promotes tumor invasion and metastasis [10,11] is frequently present in HCC specimens [12].”
Lee, J. E., Shin, S.-H., Shin, H., Chun, Y., & Park, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-39843-6 · Cited by 39
Jang, T., Calaoagan, J. M., Kwon, E. E., Samuelsson, S. J., Recht, L. D., & Laderoute, K. R. (2010) · International Journal of Cancer · doi:10.1002/ijc.25558 · Cited by 39
Bordji, K., Grandval, A., Cuhna-Alves, L., Lechapt, E., & Bernaudin, M. (2014) · FEBS Journal · doi:10.1111/febs.13062 · Cited by 39
Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
Trejo‐Solís, C., Castillo‐Rodríguez, R. A., Serrano-García, N., Silva‐Adaya, D., Vargas-Cruz, S., Chávez-Cortéz, E. G., Gallardo‐Pérez, J. C., Zavala-Vega, S., Cruz-Salgado, A., & Magaña-Maldonado, R. (2024) · Metabolites · doi:10.3390/metabo14050249 · Cited by 41
“Thus, HIF1 α induces Glu uptake and increases lactate production from pyruvate [182,185,186].”
BackgroundSaigusa, S., Tanaka, K., Toiyama, Y., Yokoe, T., Okugawa, Y., Koike, Y., Fujikawa, H., Inoue, Y., Miki, C., & Kusunoki, M. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.09.012 · Cited by 38
“Hypoxia inducible factor-1 (HIF-1) plays significant roles in tumorigenesis, including the processes of angiogenesis, metabolism, proliferation and differentiation [6,7].”
BackgroundHypoxic stress‐induced changes in adrenergic function: role of HIF1α
Tai, T. C., Wong‐Faull, D. C., Claycomb, R., & Wong, D. L. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05978.x · Cited by 37
Chang, L., Chen, C., Huang, D., Pai, H., Pan, S., & Teng, C. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22428 · Cited by 40
“In previous studies, thrombin was identified as a potential inducer of cancer cell functions, such as cell growth, metastasis, and angiogenesis (Nierodzik and Karpatkin, 2006) in addition to activation of several transcription factors including HIF-1a (Richard et al., 2000; Gorlach et al., 2001).”
BackgroundZhou, Z.-L., Luo, Z.-G., Yu, B., Jiang, Y., Chen, Y., Feng, J.-M., Dai, M., Tong, L.-J., Li, Z., Li, Y.-C., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-268 · Cited by 38
“To function as a transcription factor, HIF-1a heterodimerizes HIF-1b that is constitutively expressed [2].”
BackgroundHill, C. N., Hernández‐Cáceres, M. P., Asencio, C., Torres, B. M., Solis, B., & Owen, G. I. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.605314 · Cited by 38
Wang, N., Dong, C., Jiang, R., Tang, C., Yang, L., Jiang, Q., Chen, G. G., & Liu, Z. (2014) · Europe PMC (PubMed Central) · Cited by 37
Gundemir, S., Colak, G., Feola, J., Blouin, R., & Johnson, G. V. W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.011 · Cited by 37
“HIF-dependent transcription has great relevance to at least two major pathologies: cancer [58] and stroke [59,60].”
BackgroundAndo, H., Natsume, A., Iwami, K., Ohka, F., Kuchimaru, T., Kizaka‐Kondoh, S., Ito, K., Saito, K., Sugita, S., Hoshino, T., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.044 · Cited by 39
Integrin α6 (CD49f), The Microenvironment and Cancer Stem Cells
Bigoni-Ordóñez, G. D., Czarnowski, D., Parsons, T. M., Madlambayan, G. J., & Villa-Diaz, L. (2018) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x13666181002151330 · Cited by 25
Hu, H., Miao, X., Li, J., Zhang, X., Xu, J., Zhang, J., Zhou, T., Hu, M.-N., Yang, W., & Mou, L. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172961 · Cited by 37
Jin, Y., Che, X., Qu, X., Li, X., Lü, W., Wu, J., Wang, Y., Hou, K., Li, C., Zhang, X., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01612 · Cited by 37
Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma
Shou, Z., Li, L., Liang, J., Li, J., & Chen, H. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1125-7 · Cited by 37
“Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric basic helix-loop-helix transcription factor composed of two subunits, HIF-1a and HIF-1b (Rankin and Giaccia 2008).”
BackgroundLiu, F., Dong, X., LV, H., Xiu, P., Li, T., WANG, F., Xu, Z., & Li, J. (2015) · Oncology Letters · doi:10.3892/ol.2015.3315 · Cited by 36
“Solid tumors often have a hypoxic internal microenvironment that includes numerous molecular pathways, which provide challenges for therapeutic strategies; this microenvironment is the primary cause of drug resistance to antitumor therapies (8,9).”
Maroni, P., Matteucci, E., Luzzati, A., Perrucchini, G. G., Bendinelli, P., & Desiderio, M. A. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1240-1 · Cited by 35
“HIF-1α is an anti-apoptotic gene [14, 44, 45], while COX-2 is pro-apoptotic [46].”
BackgroundShi, Y., Chang, M., Wang, F., Ouyang, X., Jia, Y., & Du, H. (2010) · Oncology Letters · doi:10.3892/ol_00000115 · Cited by 36
“HIF-1 is considered to be the most important family member as it is known to be crucial for tumorigenesis (9).”
Culver, C. A., Melvin, A., Mudie, S., & Rocha, S. (2011) · Cell Cycle · doi:10.4161/cc.10.8.15326 · Cited by 36
“HIF-1α levels are elevated in both hypoxic and normoxic regions of tumors.(1,13-15) Normoxic activation of HIF has been attributed to genetic alterations within the oxygen sensing pathway, such as VHL inactivation and activation of cell signaling pathways such as the PI-3 kinase/AKT pathway.”
BackgroundInfluentialAscorbic Acid in Cancer Chemoprevention: Translational Perspectives and Efficacy
Ullah, M. F., Bhat, S. H., Hussain, E., Abuduhier, F. M., Ahmad, A., & Hadi, S. M. (2012) · Current Drug Targets · doi:10.2174/138945012804545669 · Cited by 36
Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma
Ikeda, S., & Tagawa, H. (2021) · Cancer Science · doi:10.1111/cas.15087 · Cited by 36
Zhao, Y., Liu, X., Shen, G., Ma, Y., Zhang, F., Chen, M., Zhao, H.-L., Yu, J., & Zhang, J. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.010 · Cited by 36
Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α
Coutts, A. S., Pires, I. M., Weston, L., Buffa, F. M., Milani, M., Li, J., Harris, A. L., Hammond, E. M., & Thangue, N. B. L. (2011) · Oncogene · doi:10.1038/onc.2011.188 · Cited by 37
“Inspection of the upstream promoter region of JMY identified several putative HRE that closely resembled the canonical sequence A/G CGTG as well as a broader, though less well-defined, sequence BACGTSSK (B¼T/ G/C; S¼G/C; K¼T/G (Rankin and Giaccia, 2008; Semenza, 2010)), in the proximal JMY promoter (Figure 2a).”
BackgroundLi, J., Cnattingus, S., Gissler, M., Vestergaard, M., Obel, C., Ahrensberg, J. M., & Olsen, J. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001095 · Cited by 36
Molecular Pathogenesis of Sporadic Melanoma and Melanoma-Initiating Cells
Kong, Y., Kumar, S. M., & Xu, X. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2009-0418-rar.1 · Cited by 36
Special techniques in surgical pathology
(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06969-4.00023-4 · Cited by 36
Mangiavini, L., Merceron, C., Araldi, E., Khatri, R., Gerard-O’Riley, R. L., Wilson, T. L., Rankin, E. B., Giaccia, A. J., & Schipani, E. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.06.013 · Cited by 35
Self-citationVistica, D. T., Hollingshead, M. G., Borgel, S. D., Kenney, S., Stockwin, L. H., Raffeld, M. A., Schrump, D. S., Burkett, S. S., Stone, G. A., Butcher, D. O., et al. (2009) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181a6e043 · Cited by 35
Hypoxia-Inducible Factor-1 Expression Predicts Osteosarcoma Patients’ Survival: A Meta-Analysis
Ouyang, Y., Li, H., Bu, J., Li, X., Chen, Z., & Xiao, T. (2016) · The International Journal of Biological Markers · doi:10.5301/jbm.5000216 · Cited by 35
“HIF-1 mediates physiological and pathophysiological responses in the cellular oxygen-signaling pathway, and plays an essential role in tumorigenesis, affecting tumor metabolism, differentiation, angiogenesis, proliferation and metastasis (35).”
BackgroundThe TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma.
Yao, L., Zou, X., & Liu, L. (2019) · PubMed Central · Cited by 35
Wolff, M., JELKMANN, W. E. B., Dunst, J., & Depping, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354487 · Cited by 35
Oguro, A., Sakamoto, K., Suzuki, S., & Imaoka, S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1962 · Cited by 35
Lee, Y., & Friedman, S. L. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385233-5.00006-4 · Cited by 37
Ishikawa, H., Xu, L., Sone, K., Kobayashi, T., Wang, G., & Shozu, M. (2018) · Reproductive Sciences · doi:10.1177/1933719118776793 · Cited by 34
“After the translocation, the HIF–transcriptional complex including HIF-1a binds to putative HREs in the promoter of HIF-responsive genes and regulates their transcription.(19) The ChIP-qPCR revealed that the recruitment of HIF-1a protein to the putative HREs in the HIF-responsive genes was increased by hypoxia in the…”
BackgroundHypoxia‐inducible factor‐1α blocks differentiation of malignant gliomas
Lu, H., Li, Y., Shu, M., Tang, J., Huang, Y., Zhou, Y., Liang, Y., & Yan, G. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07441.x · Cited by 34
Wang, W., Xu, G.-L., Jia, W.-D., Wang, Z.-H., Li, J.-S., Ma, J., Ge, Y.-S., Xie, S.-X., & Yu, J. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700217 · Cited by 34
Carrera, S., Senra, J. M., Acosta, M. I., Althubiti, M., Hammond, E. M., de Verdier, P. J., & Macip, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097938 · Cited by 37
“A growing body of evidence suggests that HIF-1 can contribute to tumour progression and metastasis [8].”
BackgroundChen, C., Ma, Q., Ma, X., Liu, Z., & Liu, X. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1587-5 · Cited by 40
Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients
Cangelosi, D., Blengio, F., Versteeg, R., Eggert, A., Garaventa, A., Gambini, C., Conte, M., Eva, A., Muselli, M., & Varesio, L. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s7-s12 · Cited by 34
“Hypoxia activates specific genes encoding angiogenic, metabolic and metastatic factors [15,18] and contributes to the acquisition of the tumor aggressive phenotype [15,19,20].”
BackgroundGlycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction
Filho, A. F. D. S., de Sena, W. L. B., de Lima, L. R. A., Carvalho, L. V. D. N., Pereira, M. C., Santos, L. G. S., Santos, R. V. C., Tavares, L. B., Pitta, M. G. D. R., & Rêgo, M. J. B. D. M. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471912 · Cited by 35
Silakit, R., Kittirat, Y., Thongchot, S., Loilome, W., Techasen, A., Ungarreevittaya, P., Khuntikeo, N., Yongvanit, P., Yang, J. H., Kim, N. H., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199827 · Cited by 34
Pellegata, N. S., Berriel Diaz, M., Rohm, M., & Herzig, S. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10058-y · Cited by 33
Ciampa, J., Yeager, M., Amundadottir, L. T., Jacobs, K. B., Kraft, P. L., Chung, C. C., Wacholder, S., Yu, K. F., Wheeler, W., Thun, M. J., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2646 · Cited by 33
“That gene belongs to a family of hypoxia-inducible factors that promote key carcinogenic processes such as angiogensis and metastasis (31).”
BackgroundShah, T. K., Krishnamachary, B., Wildes, F. B., Mironchik, Y., Kakkad, S. M., Jacob, D., Artemov, D., & Bhujwalla, Z. M. (2015) · Oncotarget · doi:10.18632/oncotarget.4612 · Cited by 34
“The adaptive response of cells to low oxygen tension is mediated through the hypoxiainducible factor (HIF) [3].”
InfluentialDNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications
Thomas, I. B. K., Gaminda, K. A. P., Jayasinghe, C. D., Abeysinghe, T., & Senthilnithy, R. (2021) · Journal of Nucleic Acids · doi:10.1155/2021/9365081 · Cited by 35
“Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcriptional factor composed of HIF-α and HIF-β [127] and plays key roles in regulating tumor radiosensitivity [128].”
BackgroundGlucose Transporters in Sex Steroid Hormone Related Cancer
Nualart, F., García, M. D. L. Á., Medina, R. A., & Owen, G. I. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109789043928 · Cited by 33
Evolution of the HIF targeted therapy in clear cell renal cell carcinoma
Golijanin, B., Malshy, K., Khaleel, S. S., Lagos, G., Amin, A., Liang Cheng, C., Golijanin, D., & Mega, A. E. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102645 · Cited by 33
Zhu, X., Zhou, W., Cui, Y., Zhu, L., Li, J., Feng, X., Shao, B., Qi, H. Y., Zheng, J., Wang, H., et al. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9467-2 · Cited by 32
In vivo modulation of 4E binding protein 1 (4E-BP1) phosphorylation by watercress: a pilot study
Alwi, S. S. S., Cavell, B. E., Telang, U., Morris, M. E., Parry, B. M., & Packham, G. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510002217 · Cited by 32
“We demonstrated that PEITC interfered with the ability of hypoxia to activate hypoxia-inducible factor (HIF)((24)), a key transcription factor that mediates cellular responses to low pO2 ((25,26)).”
Wei, R., Kong, L., Xiao, Y., Yuan, H., Song, Y., Wang, J., Yu, H., Mao, S., & Xu, W. M. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.05.033 · Cited by 32
Li, Q., Xie, Y., Cui, Z., Hai, H., Yang, H., Yuan, B., Shen, P., & Shi, C. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.102044 · Cited by 35
Methylseleninic acid downregulates hypoxia‐inducible factor‐1α in invasive prostate cancer
Sinha, I., Null, K., Wolter, W., Suckow, M. A., King, T. S., Pinto, J. T., & Sinha, R. (2011) · International Journal of Cancer · doi:10.1002/ijc.26141 · Cited by 32
“It is well established that HIF-1a is induced both by hypoxia and PI3K pathway in several cell types.(20,42,43) Even though several reports including ours(31,44) showed that selenium compounds could influence PI3K/Akt pathway in various cancer cell lines, this interaction has yet to be addressed under hypoxic conditio…”
BackgroundPrognostic relevance of hypoxia inducible factor-1α expression in patients with melanoma
Valencak, J., Kittler, H., Schmid, K., Schreiber, M., Raderer, M., Inchaurraga, M. A. G., Birner, P., & Pehamberger, H. (2009) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2009.03706.x · Cited by 32
Cangelosi, D., Muselli, M., Parodi, S., Blengio, F., Becherini, P., Versteeg, R., Conte, M., & Varesio, L. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s5-s4 · Cited by 32
“Hypoxia activates specific genes encoding angiogenic, metabolic and metastatic factors [18,21] and contributes to the acquisition of the tumor aggressive phenotype [18,22,23].”
BackgroundGRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1α destabilization
Liu, Q., Wang, L., Wang, Z., Yang, Y., Tian, J., Liu, G., Guan, D., Cao, X., Zhang, Y., & Hao, A. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt125 · Cited by 32
“It acts as a transcriptional factor to activate genes that permit metabolic adaptation, such as HK2, GLUT-1 and PDK1, and facilitate production of VEGF (33).”
BackgroundGalán‐Cobo, A., Ramírez‐Lorca, R., Serna‐Gallego, A., & Echevarrı́a, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137692 · Cited by 32
“Hence the similar effect over HIF stability displayed by the three AQPs would suggest a common mechanism in this process [17].”
BackgroundSerum amyloid A1 is upregulated in human glioblastoma
Knebel, F. H., Uno, M., Galatro, T. F. D. A., Bellé, L. P., Oba‐Shinjo, S. M., Marie, S. K. N., & Čampa, A. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2386-z · Cited by 32
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter
Longo, S. L., Griffith, C. C., Glass, A. M., Shillitoe, E. J., & Post, D. E. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.62 · Cited by 32
“One strategy involves transcriptional regulation of infected cell polypeptide 4 (ICP4) 10 .”
InfluentialNurwidya, F., Takahashi, F., Minakata, K., Murakami, A., & Takahashi, K. (2012) · Anatomy & Cell Biology · doi:10.5115/acb.2012.45.2.73 · Cited by 35
Targeting corneal inflammation by gene therapy: Emerging strategies for keratitis
Torrecilla, J., del Pozo‐Rodríguez, A., Vicente-Pascual, M., Solinís, M. Á., & Rodríguez‐Gascón, A. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.07.006 · Cited by 32
Exploiting S-nitrosylation for cancer therapy: facts and perspectives
Rizza, S., & Filomeni, G. (2020) · Biochemical Journal · doi:10.1042/bcj20200064 · Cited by 31
The GTPase RAB20 is a HIF target with mitochondrial localization mediating apoptosis in hypoxia
Hackenbeck, T., Huber, R., Schietke, R. E., Knaup, K. X., Monti, J., Wu, X., Klanke, B., Frey, B., Gaipl, U. S., Wullich, B., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.10.019 · Cited by 31
“The latter is often discussed as being important in tumor progression, as well as therapy resistance [18].”
BackgroundMao, S., Liu, Y., Morgan, J. B., Jekabsons, M. B., Zhou, Y., & Nagle, D. G. (2009) · Journal of Natural Products · doi:10.1021/np900444m · Cited by 31
Honokiol inhibits hypoxia-inducible factor-1 pathway
Lan, K.-L., Lan, K., Sheu, M., Chen, M., Shih, Y.-S., Hsu, F.-C., Wang, H.-M., Liu, R., & Yen, S.-H. (2011) · International Journal of Radiation Biology · doi:10.3109/09553002.2011.568572 · Cited by 31
“It serves as a transcription factor through binding to the hypoxia-responsive element (HRE), thereby regulating the expression of numerous genes linked to tumour progression and poor prognosis (Rankin and Giaccia 2008).”
BackgroundCavell, B. E., Alwi, S. S. S., Donlevy, A. M., Proud, C. G., & Packham, G. (2012) · Journal of Natural Products · doi:10.1021/np300049b · Cited by 31
Controlling matrix formation and cross-linking by hypoxia in cardiovascular tissue engineering
van Vlimmeren, M. A. A., Driessen‐Mol, A., van den Broek, M., Bouten, C. V. C., & Baaijens, F. F. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00571.2010 · Cited by 31
Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma
Jenkins, N., Kalra, R. R., Dubuc, A. M., Sivakumar, W., Pedone, C. A., Wu, X., Taylor, M. D., & Fults, D. W. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0085-y · Cited by 31
“in oncology as the constitutively expressed binding partner of the hypoxia-inducible transcription factors HIF1α and HIF2α, whose downstream target genes play active roles in angiogenesis, proliferation, invasion, and metastasis (reviewed in [37]).”
BackgroundChronic systemic hypoxia promotes LNCaP prostate cancer growth in vivo
Terraneo, L., Bianciardi, P., Caretti, A., Ronchi, R., & Samaja, M. (2010) · The Prostate · doi:10.1002/pros.21160 · Cited by 29
“Indeed, HIF-1a activation in cancer may also stem from O2-independent pathways, as for example the phosphatidylinositol-3-OH kinase (PI3K) signaling path [8].”
BackgroundHypoxia induces hepatocellular carcinoma metastasis via the HIF-1α/METTL16/lnc-CSMD1-7/RBFOX2 axis
Wang, Y., Yang, Y., Yang, Y., Dang, Y., Guo, Z., Zhuang, Q., Zheng, X., Wang, F., Cheng, N., Liu, X., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108495 · Cited by 30
Borsi, E., Perrone, G., Terragna, C., Martello, M., Zamagni, E., Tacchetti, P., Pantani, L., Brioli, A., Dico, A. F., Zannetti, B. A., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.018 · Cited by 30
“[23] E.”
BackgroundRecent drug therapies for corneal neovascularization
Liu, X., Wang, S., Wang, X., Liang, J., & Zhang, Y. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13018 · Cited by 32
Bogeas, A., Morvan-Dubois, G., El-Habr, E. A., Lejeune, F., Defrance, M., Narayanan, A., Kuranda, K., Burel‐Vandenbos, F., Sayd, S., Delaunay, V., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1783-x · Cited by 29
“ARNT2, like its paralog ARNT, is considered to act as a dimerization partner of HIF1/2α, the heterodimers triggering the expression of hypoxia-related genes [46, 61].”
BackgroundSaccà, C. D., Gorini, F., Ambrosio, S., Amente, S., Faicchia, D., Matarese, G., Lania, L., & Majello, B. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.03.004 · Cited by 30
Chen, Y., Li, X., Wu, S., Xu, G., Zhou, Y., Gong, L., Li, Z., & Yang, D. (2014) · Medical Oncology · doi:10.1007/s12032-014-0304-1 · Cited by 31
“mined by the expression and activity of HIF-1a [4].”
BackgroundLluis, J. M., Llacuna, L., von Montfort, C., Bárcena, C., Enrich, C., Morales, A., & Fernández-Checa, J. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008059 · Cited by 30
“Hypoxia is a prominent characteristic of advanced solid tumors and a major determinant of malignant progression and therapy responsiveness [1–2].”
Zhou, C., Liu, J., Tang, Y., Zhu, G., Zheng, M. H., Jiang, J. D., Yang, J., & Liang, X. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01114.x · Cited by 31
Adrenomedullin is a therapeutic target in colorectal cancer
Wang, L., Gala, M. K., Yamamoto, M., Pino, M. S., Kikuchi, H., Shue, D. S., Shirasawa, S., Austin, T. R., Lynch, M. P., Rueda, B. R., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28542 · Cited by 30
A HIF-1α-driven feed-forward loop augments HIF signalling in Hep3B cells by upregulation of ARNT
Mandl, M., Lieberum, M.-K., & Depping, R. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.187 · Cited by 30
“Hypoxia-dependent upregulation of ARNT is mediated by HIF-1α.”
BackgroundInfluentialCXCR7 promotes melanoma tumorigenesis via Src kinase signaling
Xu, S., Tang, J., Wang, C., Liu, J., Fu, Y., & Luo, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1442-3 · Cited by 32
Campos, M., & Albrecht, L. V. (2023) · Cancers · doi:10.3390/cancers16010016 · Cited by 33
“…promotes tumor growth, has been tied to increased PFK1 activity through allosteric activation, typically by fructose-2,6-bisphosphate (F-2,6-BP) [19–22]. the hypoxia-inducible factor pathway, which commonly promotes tumor growth, has been tied to increased PFK1 activity through allosteric…”
BackgroundKlotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
Li, Q., Li, Y., Liang, L., Li, J., Luo, D., Liu, Q., Cai, S., & Li, X. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0241-2 · Cited by 28
“Solid tumor cells reside in a microenvironment far away from the blood vessels, leading to restricted nutrients and oxygen supply, thus tumor cells evolved an adaptation to survive under hypoxic conditions, known as hypoxic adaptations [51].”
Bacci, L., Aiello, A., Ripoli, C., Loria, R., Pugliese, D., Pierconti, F., Rotili, D., Strigari, L., Pinto, F., Bassi, P. F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164012 · Cited by 29
“The critical molecular mediators of hypoxia, the hypoxia-inducible factors HIF-1α and HIF-2α, are stabilized upon low oxygen tension and transcriptionally regulate multiple steps of tumorigenesis [16].”
BackgroundTreatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma
Suzuki, K., Nishiwaki, K., & Yano, S. (2021) · Cancers · doi:10.3390/cancers13020215 · Cited by 28
Wang, J., Jing, C., Shan, K., Chen, Y., Guo, X., Cao, Z., Mu, L., Peng, L., Zhou, M., & Li, L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i7.2191 · Cited by 31
Mandl, M., Kapeller, B., Lieber, R., & Macfelda, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.051 · Cited by 29
Chen, Y., Zhang, Y., Wang, J., Chen, N., Fang, W., Zhong, J., Liu, Y., Qin, R., Yu, X., Sun, Z. S., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12491 · Cited by 29
“Most studies ascribe the hypoxic response to the binding of canonical HIFs to functional hypoxia response elements (HREs) within the promoter of molecular targets that potently drive EMT and tumor metastasis (Rankin and Giaccia, 2008).”
BackgroundSchüz, J., Schmidt, L. S., Kogner, P., Lähteenmäki, P. M., Pal, N., Stokland, T., & Schmiegelow, K. (2010) · International Journal of Cancer · doi:10.1002/ijc.25541 · Cited by 29
“First, the low Apgar score might be a sign of hypoxia, leading to cell damage that subsequently leads to a Wilms tumor.(39,40) Second, the observed association might indicate that the neonatal treatment provided to newborns with a low Apgar score at 5 min could increase the risk of a subsequent Wilms tumor.”
BackgroundOverweight, Obesity, Oxidative Stress and the Risk of Breast Cancer
Kruk, J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.22.9579 · Cited by 28
“Indeed, elevated level of HIF-1 transcription factor has been reported in several cancers including breast (Rankin and Giaccia, 2008).”
BackgroundXin, H., Brown, J. A., Gong, C., Fan, H., Brewer, G., & Gnarra, J. R. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0435 · Cited by 29
“HIF activation stimulates transcription of several hundred genes whose products have varied functions, including nutrient uptake, glycolytic metabolism, and neovascularization (8, 9).”
Background
Metadata
- Authors
- Rankin, E. B., & Giaccia, A. J.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Giaccia, A J
- Venue
- Cell Death & Differentiation
- Published
- 2008-02-15
- Volume
- 15
- Issue
- 4
- Pages
- 678-685
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC3050610
- OpenAlex
- W2014245338
- Cited by
- 806
- References
- 105
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 30 · 2023: 34 · 2022: 43 · 2021: 42 · 2020: 39 · 2019: 38 · 2018: 33 · 2017: 44 · 2016: 45 · 2015: 48 · 2014: 56 · 2013: 51 · 2012: 46
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P01CA067166, T32CA009151)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor, carcinogenesis, oxygen signaling, hypoxia-inducible factor alpha, angiogenesis, cancer metabolism, tumor growth, metastasis, radiation response, tumor differentiation, prognosis, apoptosis, cell proliferation
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Adaptation, Physiological, Animals, Hypoxia, Cell Differentiation, Energy Metabolism, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Oxygen, Signal Transduction, Cell Hypoxia, Cell Proliferation, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review